Trade-in your old, unsupported Genevac Series 2 HT-4/8 or 12 systems for a brand new Series 3 HT Evaporator

Published: 5-Dec-2016 Featured companies: Biopharma Group
Manufacturing

After a highly successful period introducing the new Genevac Series 3 HT systems to the evaporation market, we at Biopharma Group are extending our trade-in offer on all Genevac Series 2 HT systems.



The new Series 3 HT evaporator range from Genevac represents the ultimate in solvent removal technology.

Incorporating new high performance vacuum pump, the latest touchscreen technology and a sleek ergonomic design makes optimising your evaporation processes effortless.

New intuitive touchscreen controls enhances monitoring and review of the whole evaporation process.

Genevac Series 2 HT-4X Evaporator

Genevac Series 2 HT-4X Evaporator

For popular solvent removal protocols pre-set “Press & Go” methods makes operation easy and productive even for occasional users.

Simplified manual and automatic programming means even the most complex multi-stage evaporation methods can be set-up and run quickly and easily.

Peace of mind comes as standard with patented temperature control and bumping prevention built in.





To discover more about the trade-in options available and to discuss your evaporation requirements, please contact Ian Bailey : ibailey@biopharma.co.uk or +44 (0)1962 841092



Featured companies

Biopharma is known as a leading supplier of equipment to the pharmaceutical, biotech and process industries specialising in freeze drying, solvent removal/evaporation, high...
See more

You may also like

Manufacturing

The importance and challenges of mRNA vaccines

Read more
And how the correct lyo and fill/finish equipment can support your mRNA ambitions

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020
  2. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena
  3. Memel Biotech and Therabest collaborate to develop exosome-based cell therapies The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
  4. Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
  5. How a circular economy can benefit pharma manufacturers Implementing a circular economy can be beneficial for the planet and your business, if you play your cards right

Relevant companies

See more

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

You may also like

Manufacturing

The importance and challenges of mRNA vaccines

And how the correct lyo and fill/finish equipment can support your mRNA ambitions
Manufacturing

The importance/challenges of mRNA vaccines, and how the correct lyo and fill/finish equipment can support your mRNA ambitions

This article investigates the importance of selecting the correct equipment to support the R&D and scale-up process when considering the challenges associated with the design and manufacture of mRNA vaccines
Manufacturing

Biopharma Group to take the Avestin B15 on tour in Ireland

A product specialist from Biopharma Group is set to demo the product in Ireland in May 2020
Manufacturing

Biopharma Group joins forces with UCL & PMTC

The collaboration will culminate in additional training course options on 31 March and 3-5 June respectively
Manufacturing

Biopharma Group to host free seminar in November

The talk, titled 'Advances in Preparative SFC & Supporting Evaporative Technique' will take place in November
Manufacturing

The era of pharma and biotech outsourcing is here to stay

What began as a trend across the pharmaceutical industry is now so firmly established it could be considered the norm; outsourcing of both R&D and manufacturing
Manufacturing

Collagen scaffold production: The freeze drying method

Collagen bio-scaffolds are hugely beneficial to many medical fields, therefore it is essential that the process used to develop them is as robust and viable as possible. Here, Bio Pharma Group outline the main markets, applications and importance associated when freeze drying collagen bio-scaffolds and the care that must be taken during the freezing, as well as drying steps to maximise the efficiency and ice crystal structure/target porosity
Subscribe now